A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Clinical trial NCT05869903 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05869903
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-05
- Primary completion
- 2025-07-25
- Enrollment
- 3127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.